Oct 16, 2026 08:07AM
Oct 14, 2026 06:51AM
Sep 29, 2026 07:02AM
Sep 10, 2026 09:31AM
Aug 10, 2026 07:02AM
May 15, 2026 04:50AM
May 13, 2026 04:13PM Aquestive Therapeutics Inc. (AQST) Tops Q1 EPS by 6c
May 12, 2026 09:31AM
Mar 6, 2026 04:40AM
Mar 4, 2026 04:11PM
Feb 3, 2026 06:49AM
Feb 2, 2026 07:00AM
Feb 2, 2026 06:59AM
Jan 13, 2026 10:59AM Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation
Jan 9, 2026 07:02AM
Nov 5, 2025 04:27PM
Oct 9, 2025 04:11AM
Oct 8, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 26, 2025 08:07AM
Aug 19, 2025 07:01AM Cantor Fitzgerald Reiterates Overweight Rating on Aquestive Therapeutics (AQST)
Aug 14, 2025 06:01AM
Aug 11, 2025 04:26PM
Jul 22, 2025 08:53AM
Jul 15, 2025 07:00AM
Jun 17, 2025 06:39AM
Jun 17, 2025 05:15AM
Jun 16, 2025 07:02AM Aquestive Therapeutics Inc. (AQST) Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
Jun 2, 2025 08:50AM
May 13, 2025 03:26PM
May 13, 2025 07:37AM
Apr 1, 2025 07:00AM
Mar 10, 2025 06:49AM
Mar 5, 2025 04:34PM
Mar 3, 2025 01:09PM Leerink Partners Reiterates Outperform Rating on Aquestive Therapeutics (AQST)
Feb 19, 2025 01:08PM
Feb 18, 2025 04:23AM
Dec 20, 2024 06:52AM
Dec 19, 2024 08:02AM
Dec 17, 2024 06:31AM
Dec 2, 2024 08:40AM
Dec 2, 2024 08:02AM Aquestive Therapeutics Inc. (AQST) Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm Sublingual Film
Nov 6, 2024 09:24AM
Nov 4, 2024 04:43PM
Oct 25, 2024 05:41AM
Oct 24, 2024 08:03AM
Oct 8, 2024 08:10AM
Sep 30, 2024 06:56AM
Sep 27, 2024 08:32AM Aquestive Therapeutics (AQST) Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
Aug 14, 2024 08:01AM

468,579 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All